Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | NTMT1 | Q9BV86 | 2/20 | 0.43 |
| ▸ | AVPR1A | P37288 | 6/20 | 0.42 |
| ▸ | AVPR1B | P47901 | 4/20 | 0.42 |
| ▸ | F2 | P00734 | 5/20 | 0.41 |
| ▸ | AVPR2 | P30518 | 3/20 | 0.41 |
| ▸ | OXTR | P30559 | 2/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.40 |
| ▸ | PRCP | P42785 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29750784 | 0.88 | ACE (0.45) | TLR2NTMT1F2CTRB1PRCP | |
| SCHEMBL29456966 | 0.88 | STAT3 (0.42) | AVPR1AAVPR1BF2AVPR2OXTR | |
| SCHEMBL29777648 | 0.85 | ACE (0.49) | TLR2NTMT1F2CTRB1PRCP | |
| SCHEMBL29566581 | 0.83 | CTRB1 (0.46) | F2CTRB1PRCP | |
| SCHEMBL29777564 | 0.81 | TLR2 (0.59) | TLR2 | |
| SCHEMBL30585183 | 0.81 | CTRB1 (0.45) | TLR2F2CTRB1PRCP | |
| SCHEMBL29561678 | 0.80 | CTRB1 (0.42) | TLR2F2CTRB1PRCP | |
| SCHEMBL29401177 | 0.80 | CMA1 (0.43) | F2CTRB1 | |
| SCHEMBL31297113 | 0.79 | F2 (0.47) | TLR2NTMT1F2PRCP | |
| SCHEMBL19423740 | 0.79 | TLR2 (0.62) | TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116333053-A | Atosiban and method for inhibiting formation of polymeric impurities | 海南中和药业股份有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-115038711-B | Synthesis method of atosiban | 湖北健翔生物制药有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-115038711-A | Synthetic method of atosiban | 湖北健翔生物制药有限公司 | 2022-09-09 | — | — | CN | disclosed |
| WO-2022141615-A1 | SYNTHESIS METHOD FOR ATOSIBAN | 湖北健翔生物制药有限公司 | 2022-07-07 | — | — | WO | disclosed |